Speeches & Testimony

Pew Urges Senate Committee on Aging to Maintain Drug Safety Standards

In advance of the Dec. 9 hearing, “Sudden Price Spikes in Off-Patent Drugs: Perspectives From the Front Lines,” Allan Coukell, senior director of health programs at The Pew Charitable Trusts, sent a letter to members of the U.S. Senate Special Committee on Aging.  In the letter, Coukell highlights the risks of relying on compounded drugs—medicines made by pharmacies—as substitutes for FDA-approved drugs to address drug pricing concerns, and he urges Congress to work on solutions that maintain important standards of drug safety, effectiveness, and manufacturing quality.  

Media Contact

Erin Davis

Officer, Communications